Antileishmanial activity of the chalcone derivative LQFM064 associated with reduced fluidity in the parasite membrane as assessed by EPR spectroscopy
Nenhuma Miniatura disponível
Data
2020
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
A novel chalcone derivative, LQFM064, demonstrated antileishmanial activity against Leishmania (L.) amazonensis,
with an IC50 value of ~10 μM for the promastigote form. Electron paramagnetic resonance (EPR) spectroscopy
of a spin-labeled stearic acid incorporated in the plasma membrane of L. amazonensis promastigotes
revealed that after 2 h of treatment with LQFM064, the parasite showed remarkable reductions in membrane
fluidity. The features of the altered EPR spectra were similar to those reported for the erythrocyte membrane,
which was suggested to be due to the cross-linking of oxidized hemoglobin with the cytoskeleton spectrin. In
comparison to miltefosine (MIL), LQFM064 demonstrated a much lower hemolytic potential against both erythrocytes
in PBS and whole blood, less cytotoxicity in J774.A1 macrophages and equivalent ability to kill
parasites internalized in J774.A1 macrophages. Measurements of the IC50 values for assays with different cell
concentrations enabled the estimation of the membrane-water partition coefficient (KM/W), as well as the concentrations
of LQFM064 in membrane (cm50) and aqueous phase (cw50) that reduces the cell population by 50%.
From the KM/W and cm50 values it was deduced that LQFM064 has a greater affinity than MIL for the parasite
membrane, but the antiproliferative activity of both substances is exerted at a similar concentration in the
plasma membrane.
Descrição
Palavras-chave
Leishmania, Electron paramagnetic resonance, Macrophages, Erythrocyte, Membrane fluidity
Citação
ALONSO, Lais; MENEGATTI, Ricardo; GOMES, Rodrigo Saar; DORTA, Miriam Leandro; LUZIN, Rangel Magalhães; LIÃO, Luciano Morais; ALONSO, Antonio. Antileishmanial activity of the chalcone derivative LQFM064 associated with reduced fluidity in the parasite membrane as assessed by EPR spectroscopy. European Journal of Pharmaceutical Sciences, Amsterdam, v. 151, p. 105407, 2020. DOI: 10.1016/j.ejps.2020.105407. Disponível em: https://www.sciencedirect.com/science/article/pii/S0928098720301962?via%3Dihub. Acesso em: 14 abr. 2023.